InsidersTradesSigma
Track the RetinalGenix Technologies Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €75.4m. The latest transaction was filed on 10 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Steven Bayern for Bayern Capital LLC. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
RetinalGenix Technologies Inc. es una empresa centrada en el desarrollo de soluciones tecnológicas para la salud ocular. Cotiza en NASDAQ bajo el ticker XNAS.